• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch Health Companies Inc (NY: BHC )

    5.765 +0.035 (+0.61%)
    Streaming Delayed Price Updated: 3:19 PM EDT, Aug 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bausch Health Companies Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
    Via ACCESSWIRE
    Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock
    Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing... 
    Via Benzinga
    US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
    Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... 
    Via Benzinga
    Bausch Health Announces Second Quarter 2024 Results
    Via ACCESSWIRE
    Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
    The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
    After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... 
    Via Benzinga
    BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy
    Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism. 
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    Why Bausch health Shares Are Falling Today
    Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged... 
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Bausch Health Responds to Market Rumors
    Via ACCESSWIRE
    Bausch Health Welcomes Two New Members to the Executive Leadership Team
    Via ACCESSWIRE
    Bausch Health Announces 2024 Annual Meeting of Shareholder Results
    Via ACCESSWIRE
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Stocks Plummet After Tech Earnings, Manufacturing Data
    The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Why Bausch Health Companies Shares Are Falling After Q1 Results
    Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%. 
    Via Benzinga
    Bausch Health Announces First Quarter 2024 Results
    Via ACCESSWIRE
    Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
    Via ACCESSWIRE
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
    Via ACCESSWIRE
    Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
    Via ACCESSWIRE
    Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
    Via ACCESSWIRE
    Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
    Via ACCESSWIRE
    Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
    Via ACCESSWIRE
    Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
    Via ACCESSWIRE
    Why Bausch Health Companies Stock Dived by More Than 7% Today
    A large red number on the bottom line attracted the wrong kind of investor attention for the company. 
    Via The Motley Fool
    BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024
    BHC stock results show that Bausch Health Companies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Bausch Health to Announce First-Quarter 2024 Results on May 2
    Via ACCESSWIRE
    Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
    Via ACCESSWIRE
    Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
    Via ACCESSWIRE
    Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
    Via ACCESSWIRE
    Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
    Via ACCESSWIRE
    Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
    Via ACCESSWIRE
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.